Corporate development

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES ACQUISITION OF HEALTHBEACON PLC

Retrieved on: 
Monday, February 5, 2024

GLEN ALLEN, Va., Feb. 5, 2024 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) today announced that through its Hamilton Beach Health subsidiary it has acquired HealthBeacon PLC, a medical technology firm and strategic partner of the company.

Key Points: 
  • GLEN ALLEN, Va., Feb. 5, 2024 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) today announced that through its Hamilton Beach Health subsidiary it has acquired HealthBeacon PLC, a medical technology firm and strategic partner of the company.
  • Gregory H. Trepp, president and chief executive officer of Hamilton Beach Brands Holding Company, said, "This acquisition is a key step in support of our strategic initiative to expand in the fast-growing home health and wellness market, and it strengthens our participation in the home medical category.
  • Drawing on decades of experience as a trusted resource in the home, in 2021 we created the Hamilton Beach Health® brand.
  • Rob George, who has been serving as Vice President of Corporate Development and Strategy for Hamilton Beach Brands, focusing principally on the home medical market, has been named Global General Manager, Hamilton Beach Health to drive global expansion of this business.

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

Retrieved on: 
Thursday, February 1, 2024

SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that Jack Lu, the Company’s Director of Corporate Development, will present live at the Small-Cap Growth Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on February 7, 2024.

Key Points: 
  • SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced that Jack Lu, the Company’s Director of Corporate Development, will present live at the Small-Cap Growth Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on February 7, 2024.
  • This will be a live, interactive online event where investors are invited to ask the company questions in real-time.
  • If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
  • It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

Sandoz announces changes in the Board of Directors

Retrieved on: 
Thursday, February 1, 2024

53 SIX Swiss Exchange Listing Rules

Key Points: 
  • 53 SIX Swiss Exchange Listing Rules
    Basel, February 1, 2024 - The Board of Directors of Sandoz announced today that it proposes Graeme Pitkethly for election to its Board of Directors at the company’s next Annual General Meeting on April 30, 2024.
  • If elected by the shareholders at the upcoming Annual General Meeting, the Board intends to appoint Graeme Pitkethly as Chair of its Audit, Risk and Compliance Committee.
  • François-Xavier Roger has been a Sandoz Board member and Chair of the Audit, Risk and Compliance Committee since August 2023.
  • Graeme serves as a member of the Board of Directors of Pearson plc since 2019 and chairs the Audit Committee.

Fairfax Announces Acquisition of Additional Orla Shares

Retrieved on: 
Wednesday, January 31, 2024

TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has acquired, through its insurance company subsidiaries, 2,000,000 common shares (the “Common Shares”) of Orla Mining Ltd. (TSX: OLA) (“Orla”) at a price of $4.65 per Common Share for an aggregate purchase price of approximately $9,300,000 through the facilities of the Toronto Stock Exchange (the “Share Purchase”).

Key Points: 
  • TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has acquired, through its insurance company subsidiaries, 2,000,000 common shares (the “Common Shares”) of Orla Mining Ltd. (TSX: OLA) (“Orla”) at a price of $4.65 per Common Share for an aggregate purchase price of approximately $9,300,000 through the facilities of the Toronto Stock Exchange (the “Share Purchase”).
  • The Share Purchase represents approximately 0.64% of the issued and outstanding Common Shares of Orla and brings Fairfax’s total holdings, through its insurance subsidiaries, of such securities to 48,611,791 Common Shares (or approximately 15.46% of all Common Shares).
  • Immediately prior to the Share Purchase, Fairfax, through its insurance company subsidiaries, beneficially owned and controlled 46,611,791 Common Shares, representing approximately 14.82% of the issued and outstanding Common Shares of Orla.
  • Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty insurance and reinsurance and the associated investment management.

Nanoxplore expands capacity in Quebec plant to accommodate higher customer volumes and announces the nomination of Pierre-Yves Terrisse, Vice-President corporate development

Retrieved on: 
Tuesday, January 30, 2024

This capacity expansion, which is part of its 5-year strategic plan and related to the SMC lightweighting initiative, begins immediately.

Key Points: 
  • This capacity expansion, which is part of its 5-year strategic plan and related to the SMC lightweighting initiative, begins immediately.
  • Moreover, a significant part of the capacity expansion costs will be assumed by the customer.
  • His network of institutional investors, sell-side financial community, combined with his expertise, will reinforce the Corporation's profile and strength.
  • NanoXplore is a leader in graphene production, and I see solid organic and inorganic growth opportunities ahead for the company.”

Patterson Companies Elects Pamela Tomczik to Board of Directors

Retrieved on: 
Friday, February 2, 2024

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024.

Key Points: 
  • Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024.
  • “As we continue to enhance the finance, strategy and corporate development experience on our Board, we are excited to welcome Pamela to the Board of Directors,” said John D. Buck, Chairman of the Board of Patterson Companies.
  • “Pamela is a skilled finance executive with extensive experience in the treasury and M&A functions at various companies and will provide valuable strategic insights and enhance the diversity of perspectives on our Board.
  • Prior to joining Target, Ms. Tomczik held several leadership positions at Thomson Reuters, including Vice President of Corporate Development.

Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal

Retrieved on: 
Thursday, February 1, 2024

PRN-001-01 (tezampanel) is a novel small molecule compound that will be the first parenteral therapeutic to be evaluated for the treatment of symptoms associated with opiate withdrawal in a Phase 1 clinical study.

Key Points: 
  • PRN-001-01 (tezampanel) is a novel small molecule compound that will be the first parenteral therapeutic to be evaluated for the treatment of symptoms associated with opiate withdrawal in a Phase 1 clinical study.
  • In conjunction with the Series B financing, Proniras has appointed Steven Gillis, Ph.D., as Chairman and Atul Saran as an independent member to the Company’s Board of Directors.
  • "Their wealth of knowledge and industry experience will be instrumental in guiding Proniras through its next phase of growth.
  • We look forward to their leadership and contributions as we continue to advance Proniras through the next stages of product development."

Allison Transmission to Drive Innovation with New Venture Capital Arm

Retrieved on: 
Tuesday, January 30, 2024

Allison Transmission, a leading designer and manufacturer of conventional and electrified vehicle propulsion solutions and the largest global manufacturer of medium- and heavy-duty fully automatic transmissions for commercial and defense vehicles, today announced it is launching Allison Ventures.

Key Points: 
  • Allison Transmission, a leading designer and manufacturer of conventional and electrified vehicle propulsion solutions and the largest global manufacturer of medium- and heavy-duty fully automatic transmissions for commercial and defense vehicles, today announced it is launching Allison Ventures.
  • Allison Ventures is not a separate investment fund but embedded within Allison’s corporate team.
  • “Allison Ventures will allow us to increase our innovation pipeline in support of industry technology advancement across commercial-duty mobility and work solutions to further our mission to Improve the Way the World Works," said Todd Bradford, Vice President, Strategy, Business and Corporate Development, Allison Transmission.
  • The Allison Ventures team will focus on technologies that will shape the future of commercial-duty mobility and work solutions.

Kreshmore Group 2023 Year in Review

Retrieved on: 
Tuesday, January 30, 2024

As the calendar turns to 2024, Kreshmore Group (KG) celebrates another successful transactional track record and its 14th year in business.

Key Points: 
  • As the calendar turns to 2024, Kreshmore Group (KG) celebrates another successful transactional track record and its 14th year in business.
  • Kreshmore is grateful for its teams’ efforts and the professional alignments it has secured within the financial industry.
  • “We thank our supporters – from our investors to our deal partners – for what we accomplished together in 2023,” said Joseph B. Wabick, Managing Partner of Kreshmore Group.
  • We anticipate having a greater ability to take on more client work and accelerate critical growth levers in 2024.”

Great-West Lifeco announces retirement of Arshil Jamal

Retrieved on: 
Thursday, February 1, 2024

David Harney to assume expanded role as President and COO, Europe and CRS

Key Points: 
  • David Harney to assume expanded role as President and COO, Europe and CRS
    WINNIPEG, MB, Feb. 1, 2024 /CNW/ - Great-West Lifeco today announced the upcoming retirement of Arshil Jamal from his position as President and Group Head, Strategy, Investments, Reinsurance and Corporate Development.
  • Arshil has been with the company for over 25 years, serving in a variety of roles including nine years as the company's President and Chief Operating Officer, Europe and Reinsurance.
  • "Over the course of his career with Lifeco, Arshil has made significant contributions to our success and set the stage for continued growth," said Paul Mahon, President and CEO, Great-West Lifeco.
  • "On behalf of the Board of Directors and our entire organization, I want to thank Arshil for his commitment to our company, colleagues and our customers."